# Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99

> **NCT00931086** · — · NO_LONGER_AVAILABLE · sponsor: **Human Genome Sciences Inc., a GSK Company**

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** belimumab

## Key facts

- **NCT ID:** NCT00931086
- **Lead sponsor:** Human Genome Sciences Inc., a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** 2009-04
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** — (—)
- **Last updated:** 2012-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931086, "Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00931086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*